NCT01491503View on ClinicalTrials.gov

A Drug Interaction Study of Montelukast and Levocetirizine

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Healthy
Interventions
DRUG

Levocetirizine

Levocetirizine dihydrochloride 5mg. PO. Single dose.

DRUG

montelukast sodium

Montelukast sodium 10mg. PO. Single dose.

DRUG

Montelukast & levocetirizine

Montelukast sodium 10mg \& levocetirizine dihydrochloride 5mg PO. Single dose.

Trial Locations (1)

Unknown

Samsung medical center, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT01491503 - A Drug Interaction Study of Montelukast and Levocetirizine | Biotech Hunter | Biotech Hunter